哮喘：短效β受体激动剂（SABA）吸入器处方过量对医疗资源利用的影响。 - Suppr

Suppr

超能文献

Asthma: effect of excess short-acting β-agonist (SABA) inhaler prescriptions on healthcare resource utilisation.

作者信息

Levy Mark L, Capstick Toby Gd, Antalffy Thomas

机构信息

Kenton Bridge Medical Centre, Harrow.

Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds.

出版信息

Br J Gen Pract. 2024 Jul 25;74(745):374-376. doi: 10.3399/bjgp24X739089. Print 2024 Aug.

DOI:10.3399/bjgp24X739089

PMID:39054088

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11299697/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/11299697/bb61e2af441b/bjgpaug-2024-74-745-374.jpg

相似文献

Asthma: effect of excess short-acting β-agonist (SABA) inhaler prescriptions on healthcare resource utilisation.

Br J Gen Pract. 2024 Jul 25;74(745):374-376. doi: 10.3399/bjgp24X739089. Print 2024 Aug.

Knowledge, practice pattern and attitude toward asthma management amongst physicians from Nepal, Malaysia, Lebanon, Myanmar and Morocco.

J Asthma. 2021 Jul;58(7):979-989. doi: 10.1080/02770903.2020.1742351. Epub 2020 Apr 17.

Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian Asthma population.

NPJ Prim Care Respir Med. 2024 Nov 3;34(1):35. doi: 10.1038/s41533-024-00391-w.

SABA prescriptions and asthma management practices in Singapore: results from a cross-sectional, observational SABINA III study.

BMJ Open. 2024 Jun 10;14(6):e064245. doi: 10.1136/bmjopen-2022-064245.

Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia.

J Asthma. 2018 Jun;55(6):684-694. doi: 10.1080/02770903.2017.1353611. Epub 2017 Sep 8.

Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase.

J Asthma. 2018 May;55(5):571-577. doi: 10.1080/02770903.2017.1348513. Epub 2017 Aug 16.

Single inhaler combination inhaled corticosteroid-formoterol as both maintenance and reliever (SMART) compared with a step up of treatment with fixed-dose inhaled corticosteroid-long-acting β2-agonist maintenance with a short-acting β2-agonist as reliever in adolescents and adults with poorly controlled asthma in Colombia: a cost-utility analysis.

J Asthma. 2025 Mar;62(3):500-507. doi: 10.1080/02770903.2024.2410424. Epub 2024 Oct 1.

Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.

NPJ Prim Care Respir Med. 2024 Aug 20;34(1):23. doi: 10.1038/s41533-024-00382-x.

Short-acting β-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.

Respir Med. 2024 Sep;231:107723. doi: 10.1016/j.rmed.2024.107723. Epub 2024 Jun 25.

SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population.

BMC Pulm Med. 2024 May 14;24(1):232. doi: 10.1186/s12890-024-03038-1.

引用本文的文献

How to move towards more sustainable asthma care in Europe: an expert opinion paper.

Breathe (Sheff). 2025 May 13;21(2):240229. doi: 10.1183/20734735.0229-2024. eCollection 2025 Apr.

本文引用的文献

A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy.

Br J Gen Pract. 2024 Jan 25;74(739):86-89. doi: 10.3399/bjgp24X736353. Print 2024 Feb.

Regular (up to 10 puffs 4-hourly) inhaled salbutamol should be prescribed at discharge after an asthma attack: myth or maxim?

Breathe (Sheff). 2023 Sep;19(3):230054. doi: 10.1183/20734735.0054-2023. Epub 2023 Oct 10.

Healthcare costs associated with short-acting β-agonists in asthma: observational UK SABINA study.

BJGP Open. 2023 Sep 19;7(3). doi: 10.3399/BJGPO.2023.0015. Print 2023 Sep.

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.

NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7. doi: 10.1038/s41533-023-00330-1.

The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.

J Allergy Clin Immunol Pract. 2023 Mar;11(3):762-772.e1. doi: 10.1016/j.jaip.2023.01.002. Epub 2023 Jan 10.

Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.

J Allergy Clin Immunol Pract. 2022 Sep;10(9):2297-2309.e10. doi: 10.1016/j.jaip.2022.02.047. Epub 2022 Mar 29.

Overuse of short-acting β-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.

Eur Respir J. 2020 Apr 16;55(4). doi: 10.1183/13993003.01872-2019. Print 2020 Apr.

Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London.

NPJ Prim Care Respir Med. 2016 Aug 18;26:16049. doi: 10.1038/npjpcrm.2016.49.

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):604-10. doi: 10.1164/ajrccm.149.3.8118625.

Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.

Eur Respir J. 1994 Sep;7(9):1602-9. doi: 10.1183/09031936.94.07091602.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验